社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Quince Therapeutics, Inc.(QNCX)
盘后
0.1864
-0.01
-6.80%
19:59 EST
0.2000
-0.0255
-11.31%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
刘文杰兄弟
·
02-03
$Quince Therapeutics, Inc.(QNCX)$
退市，正好[龇牙]
$Quince Therapeutics, Inc.(QNCX)$ 退市，正好[龇牙]
回复
评论
点赞
2
编组 21备份 2
分享
举报
春冬
·
2024-06-21
$Quince Therapeutics, Inc.(QNCX)$
这是准备奔几分钱去的节奏
$Quince Therapeutics, Inc.(QNCX)$ 这是准备奔几分钱去的节奏
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
春冬
·
2024-05-22
$Quince Therapeutics, Inc.(QNCX)$
准备退市吧！要死不活的鬼样子
$Quince Therapeutics, Inc.(QNCX)$ 准备退市吧！要死不活的鬼样子
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Quince Therapeutics, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.quincetx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，开创了一种新型疾病改善治疗方法，用于治疗被认为是阿尔茨海默氏症和退行性疾病的关键根本原因。该公司的方法是基于在迄今通过多项研究观察到的100多名阿尔茨海默病患者的大脑中，超过90%的人的大脑中发现了牙龈porphyromonas gingivalis或P. gingivalis及其分泌的毒性毒力因子蛋白酶，称为gingipains的开创性发现。此外，该公司在动物模型中观察到牙龈假单胞菌感染会导致阿尔茨海默病理学，这些影响已在临床前研究中成功地用牙龈痛抑制剂治疗。公司专有先导候选药物COR388是一种口服给药、可穿透脑的小分子牙龈痛抑制剂。COR388在迄今为止进行的1a期和1b期临床试验中具有良好的耐受性，没有相关的安全信号，该试验共招募了67名受试者，其中包括9名轻度至中度阿尔茨海默病患者。
02-12 13:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-03
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-29
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-29
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2025-11-13
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-10-17
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-09-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-11
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-11
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-02
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-07-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-06-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-06-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-05-13
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
分时
5日
日
周
月
数据加载中...
最高
0.2976
今开
0.2807
量比
0.34
最低
0.1911
昨收
0.2255
换手率
366.23%
热议股票
{"pagemeta":{"title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Quince Therapeutics, Inc.,QNCX,Quince Therapeutics, Inc.股票,Quince Therapeutics, Inc.股票老虎,Quince Therapeutics, Inc.股票老虎国际,Quince Therapeutics, Inc.行情,Quince Therapeutics, Inc.股票行情,Quince Therapeutics, Inc.股价,Quince Therapeutics, Inc.股市,Quince Therapeutics, Inc.股票价格,Quince Therapeutics, Inc.股票交易,Quince Therapeutics, Inc.股票购买,Quince Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"QNCX","data":{"stockData":{"symbol":"QNCX","market":"US","secType":"STK","nameCN":"Quince Therapeutics, Inc.","latestPrice":0.2,"timestamp":1771016400000,"preClose":0.2255,"halted":0,"volume":181496032,"hourTrading":{"tag":"盘后","latestPrice":0.1864,"preClose":0.2,"latestTime":"19:59 EST","volume":14996483,"amount":3119703.049857,"timestamp":1771030799925,"change":-0.0136,"changeRate":-0.068,"amplitude":0.3},"delay":0,"changeRate":-0.11308203991130818,"floatShares":49558000,"shares":55681490,"eps":-1.209231,"marketStatus":"已收盘","change":-0.0255,"latestTime":"02-13 16:00:00 EST","open":0.28065,"high":0.29759,"low":0.1911,"amount":44656895.39804416,"amplitude":0.472239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.209231,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":5,"adr":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":0.2255,"preHourTrading":{"tag":"盘前","latestPrice":0.2813,"preClose":0.2255,"latestTime":"09:29 EST","volume":12392480,"amount":3381624.3759824005,"timestamp":1770992998426,"change":0.0558,"changeRate":0.24745,"amplitude":0.337916},"postHourTrading":{"tag":"盘后","latestPrice":0.1864,"preClose":0.2,"latestTime":"19:59 EST","volume":14996483,"amount":3119703.049857,"timestamp":1771030799925,"change":-0.0136,"changeRate":-0.068,"amplitude":0.3},"volumeRatio":0.341408,"impliedVol":2.862,"impliedVolPercentile":0.9004},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.528787212108808","cardData":[{"tweetId":"528787212108808","author":{"authorId":"3547890656036672","idStr":"3547890656036672","name":"刘文杰兄弟","avatar":"https://static.tigerbbs.com/33a5f809ac15686548293a70e297a54d","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/QNCX\">$Quince Therapeutics, Inc.(QNCX)$</a> 退市，正好[龇牙] ","plainDigest":"$Quince Therapeutics, Inc.(QNCX)$ 退市，正好[龇牙]","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770129612130,"gmtModify":1770129614149,"symbols":["QNCX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":145,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/528787212108808","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":46,"displayRows":4,"foldSize":0,"authorId":"3547890656036672"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.319217004949712","cardData":[{"tweetId":"319217004949712","author":{"authorId":"3562218868125807","idStr":"3562218868125807","name":"春冬","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/QNCX\">$Quince Therapeutics, Inc.(QNCX)$ </a>这是准备奔几分钱去的节奏","plainDigest":"$Quince Therapeutics, Inc.(QNCX)$ 这是准备奔几分钱去的节奏","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1718963921412,"gmtModify":1718963922806,"symbols":["QNCX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1163,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/319217004949712","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":55,"displayRows":4,"foldSize":0,"authorId":"3562218868125807"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.308459488169992","cardData":[{"tweetId":"308459488169992","author":{"authorId":"3562218868125807","idStr":"3562218868125807","name":"春冬","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/QNCX\">$Quince Therapeutics, Inc.(QNCX)$ </a>准备退市吧！要死不活的鬼样子","plainDigest":"$Quince Therapeutics, Inc.(QNCX)$ 准备退市吧！要死不活的鬼样子","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1716329392945,"gmtModify":1716329394436,"symbols":["QNCX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1239,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/308459488169992","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":58,"displayRows":4,"foldSize":0,"authorId":"3562218868125807"}],"position":0}],"size":3},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20729348","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312526047544-QNCX","pdf_url":"","pub_time":1770872400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526047544/0001193125-26-047544-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526047544/d89820d8k.htm","primary":true,"translateUrl":"","linkName":"d89820d8k.htm","type":"8-K","id":"NTFILEAWfpfVJHR3iVA5UF","market":"us","size":37779}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-12 13:00","pubTimestamp":1770872400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 8.01: Other Events","summary_zh":"第2.02项：经营业绩和财务状况；项目8.01：其他事项","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20690671","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312526033758-QNCX","pdf_url":"","pub_time":1770067828000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/0001193125-26-033758-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/d52597d8k.htm","primary":true,"translateUrl":"","linkName":"d52597d8k.htm","type":"8-K","id":"NTFILEEASmPKvHK8AfVbfb","market":"us","size":22410}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-03 05:30","pubTimestamp":1770067828,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20676967","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312526029524-QNCX","pdf_url":"","pub_time":1769662800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/0001193125-26-029524-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/d61547dex991.htm","primary":true,"translateUrl":"","linkName":"d61547dex991.htm","type":"EX-99.1","id":"NTFILEthUZDQ74BoXu5YW4","market":"us","size":14800},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/d61547d8k.htm","primary":false,"translateUrl":"","linkName":"d61547d8k.htm","type":"8-K","id":"NTFILE7bj9KsQb4ECMCm4A","market":"us","size":24268},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/g61547g0130014414374.jpg","primary":false,"translateUrl":"","linkName":"g61547g0130014414374.jpg","type":"GRAPHIC","id":"NTFILE8i4uGVuYMQaxVFPY","market":"us","size":7526}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-29 13:00","pubTimestamp":1769662800,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20579834","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828025059050-QNCX","pdf_url":"","pub_time":1766984400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"QNCX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000162828025059050/0001628280-25-059050-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1613842/000162828025059050/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE7RNn6md4hu6HQbRz","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-12-29 13:00","pubTimestamp":1766984400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20402080","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525277529-QNCX","pdf_url":"","pub_time":1762981558000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"QNCX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1662774/0001193125-25-277529-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277529/qncx-20250930.htm","primary":true,"translateUrl":"","linkName":"qncx-20250930.htm","type":"10-Q","id":"NTFILE4pbg46ox7K1zTWJ9","market":"us","size":2959443},{"description":"EX-10.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277529/qncx-ex10_1.htm","primary":false,"translateUrl":"","linkName":"qncx-ex10_1.htm","type":"EX-10.1","id":"NTFILEHApLSSY9gGcHTzYg","market":"us","size":71756},{"description":"EX-31.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277529/qncx-ex31_1.htm","primary":false,"translateUrl":"","linkName":"qncx-ex31_1.htm","type":"EX-31.1","id":"NTFILEGecT7SfxMyZLC3QS","market":"us","size":15137},{"description":"EX-31.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277529/qncx-ex31_2.htm","primary":false,"translateUrl":"","linkName":"qncx-ex31_2.htm","type":"EX-31.2","id":"NTFILE5uiAmFnQkvzFiZZD","market":"us","size":15180},{"description":"EX-32.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277529/qncx-ex32_1.htm","primary":false,"translateUrl":"","linkName":"qncx-ex32_1.htm","type":"EX-32.1","id":"NTFILE3SgqLiERV4rRC2Yo","market":"us","size":10161},{"description":"EX-32.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277529/qncx-ex32_2.htm","primary":false,"translateUrl":"","linkName":"qncx-ex32_2.htm","type":"EX-32.2","id":"NTFILEBur8fmFQZ7xbtpao","market":"us","size":10202}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-13 05:05","pubTimestamp":1762981558,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20402060","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525277523-QNCX","pdf_url":"","pub_time":1762981530000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/0001193125-25-277523-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277523/qncx-ex99_1.htm","primary":true,"translateUrl":"","linkName":"qncx-ex99_1.htm","type":"EX-99.1","id":"NTFILE2uvm95YUfXfzuhN4","market":"us","size":306505},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525277523/qncx-20251112.htm","primary":false,"translateUrl":"","linkName":"qncx-20251112.htm","type":"8-K","id":"NTFILEECCcohGhBLNbdvNy","market":"us","size":47148}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-13 05:05","pubTimestamp":1762981530,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20277299","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525242514-QNCX","pdf_url":"","pub_time":1760673600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525242514/0001193125-25-242514-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525242514/d75404d8k.htm","primary":true,"translateUrl":"","linkName":"d75404d8k.htm","type":"8-K","id":"NTFILE8guXkvsHa72ube9V","market":"us","size":24972}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-17 12:00","pubTimestamp":1760673600,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure","summary_zh":"第7.01项：法规FD披露","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20213474","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525220722-QNCX","pdf_url":"","pub_time":1758859200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525220722/0001193125-25-220722-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525220722/d911581d8k.htm","primary":true,"translateUrl":"","linkName":"d911581d8k.htm","type":"8-K","id":"NTFILEHv8bSLbms6KbKunE","market":"us","size":24992}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-26 12:00","pubTimestamp":1758859200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant","summary_zh":"第1.01项：签订重大最终协议；第2.03项：直接财务义务或注册人资产负债表外安排下的义务的产生","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19972269","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017025106535-QNCX","pdf_url":"","pub_time":1754884800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"QNCX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106535/0000950170-25-106535-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106535/qncx-20250630.htm","primary":true,"translateUrl":"","linkName":"qncx-20250630.htm","type":"10-Q","id":"NTFILECZi17eoF4WBV6L1g","market":"us","size":2999197},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106535/qncx-ex31_1.htm","primary":false,"translateUrl":"","linkName":"qncx-ex31_1.htm","type":"EX-31.1","id":"NTFILEFWPgXodCY7sVMh3r","market":"us","size":14910},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106535/qncx-ex31_2.htm","primary":false,"translateUrl":"","linkName":"qncx-ex31_2.htm","type":"EX-31.2","id":"NTFILEBJS4Bck7Y57hkrZg","market":"us","size":14953},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106535/qncx-ex32_1.htm","primary":false,"translateUrl":"","linkName":"qncx-ex32_1.htm","type":"EX-32.1","id":"NTFILEJC2yjKSj6RCL2Rm5","market":"us","size":9934},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106535/qncx-ex32_2.htm","primary":false,"translateUrl":"","linkName":"qncx-ex32_2.htm","type":"EX-32.2","id":"NTFILE3kMe9ghz9FbS9Vrr","market":"us","size":9975}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-11 12:00","pubTimestamp":1754884800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19972250","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017025106536-QNCX","pdf_url":"","pub_time":1754884800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106536/0000950170-25-106536-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106536/qncx-ex99_1.htm","primary":true,"translateUrl":"","linkName":"qncx-ex99_1.htm","type":"EX-99.1","id":"NTFILEBREHfqRwpnqmvoRe","market":"us","size":288340},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000095017025106536/qncx-20250811.htm","primary":false,"translateUrl":"","linkName":"qncx-20250811.htm","type":"8-K","id":"NTFILEBFFfB9BQ8Xi2JPdd","market":"us","size":47168}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-11 12:00","pubTimestamp":1754884800,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20126688","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525171664-QNCX","pdf_url":"","pub_time":1754079148000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"QNCX","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/0001193125-25-171664-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525171664/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE7bZSTtRTGX6w8AGj","market":"us","size":5456}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-08-02 04:12","pubTimestamp":1754079148,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19884918","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525159886-QNCX","pdf_url":"","pub_time":1752638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525159886/0001193125-25-159886-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525159886/d71020dex991.htm","primary":true,"translateUrl":"","linkName":"d71020dex991.htm","type":"EX-99.1","id":"NTFILEE7eFaoUCYNQdo3ye","market":"us","size":18752},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525159886/d71020d8k.htm","primary":false,"translateUrl":"","linkName":"d71020d8k.htm","type":"8-K","id":"NTFILE3qz3uEqdiodMo17h","market":"us","size":26714},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525159886/g71020g0716235906723.jpg","primary":false,"translateUrl":"","linkName":"g71020g0716235906723.jpg","type":"GRAPHIC","id":"NTFILEE1wqPms9oApYG5J8","market":"us","size":5340},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525159886/g71020g22m25.jpg","primary":false,"translateUrl":"","linkName":"g71020g22m25.jpg","type":"GRAPHIC","id":"NTFILE4WBAvHZyuoEbyhHX","market":"us","size":9421}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-16 12:00","pubTimestamp":1752638400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19772373","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525140873-QNCX","pdf_url":"","pub_time":1749787200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/0001193125-25-140873-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/d31831dex41.htm","primary":true,"translateUrl":"","linkName":"d31831dex41.htm","type":"EX-4.1","id":"NTFILE2fmXH639vH3XzQ1H","market":"us","size":97594},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/d31831d8k.htm","primary":false,"translateUrl":"","linkName":"d31831d8k.htm","type":"8-K","id":"NTFILEi4mD7v5E25sv8Fex","market":"us","size":35890},{"description":"EX-4.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/d31831dex42.htm","primary":false,"translateUrl":"","linkName":"d31831dex42.htm","type":"EX-4.2","id":"NTFILEAuRWEFxpRNh9otmB","market":"us","size":105623},{"description":"EX-10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/d31831dex101.htm","primary":false,"translateUrl":"","linkName":"d31831dex101.htm","type":"EX-10.1","id":"NTFILEEKZaCgJve8aje435","market":"us","size":207535},{"description":"EX-10.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000119312525140873/d31831dex102.htm","primary":false,"translateUrl":"","linkName":"d31831dex102.htm","type":"EX-10.2","id":"NTFILE7pkHLNYK7yhSf6sX","market":"us","size":117140}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-13 12:00","pubTimestamp":1749787200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19739664","market":"us","labels":[],"media":"sec.gov","original_id":"AN166277425000034-QNCX","pdf_url":"","pub_time":1749096000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"QNCX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000034/0001662774-25-000034-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000034/qncx-20250604.htm","primary":true,"translateUrl":"","linkName":"qncx-20250604.htm","type":"8-K","id":"NTFILE6zJzRxTrjEVkYyk1","market":"us","size":44036}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-05 12:00","pubTimestamp":1749096000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19635857","market":"us","labels":[],"media":"sec.gov","original_id":"AN166277425000032-QNCX","pdf_url":"","pub_time":1747108800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"QNCX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000032/0001662774-25-000032-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000032/qncx-20250331.htm","primary":true,"translateUrl":"","linkName":"qncx-20250331.htm","type":"10-Q","id":"NTFILEFcKy9K8M645iZX3i","market":"us","size":1002198},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000032/qncx-2025331xexx311.htm","primary":false,"translateUrl":"","linkName":"qncx-2025331xexx311.htm","type":"EX-31.1","id":"NTFILE8j83fj95MXP9QJms","market":"us","size":10012},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000032/qncx-2025331xexx312.htm","primary":false,"translateUrl":"","linkName":"qncx-2025331xexx312.htm","type":"EX-31.2","id":"NTFILEGaipkaRhs2csaFdS","market":"us","size":10247},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000032/qncx-2025331xexx321.htm","primary":false,"translateUrl":"","linkName":"qncx-2025331xexx321.htm","type":"EX-32.1","id":"NTFILE5zpbRTNK3CGutEqK","market":"us","size":6812},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1662774/000166277425000032/qncx-2025331xexx322.htm","primary":false,"translateUrl":"","linkName":"qncx-2025331xexx322.htm","type":"EX-32.2","id":"NTFILECbTjHPwswiiGF4Kk","market":"us","size":6850}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-13 12:00","pubTimestamp":1747108800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.quincetx.com","stockEarnings":[{"period":"1week","weight":0.5435},{"period":"1month","weight":-0.9251},{"period":"3month","weight":-0.8658},{"period":"6month","weight":-0.8666},{"period":"1year","weight":-0.8389},{"period":"ytd","weight":-0.9327}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，开创了一种新型疾病改善治疗方法，用于治疗被认为是阿尔茨海默氏症和退行性疾病的关键根本原因。该公司的方法是基于在迄今通过多项研究观察到的100多名阿尔茨海默病患者的大脑中，超过90%的人的大脑中发现了牙龈porphyromonas gingivalis或P. gingivalis及其分泌的毒性毒力因子蛋白酶，称为gingipains的开创性发现。此外，该公司在动物模型中观察到牙龈假单胞菌感染会导致阿尔茨海默病理学，这些影响已在临床前研究中成功地用牙龈痛抑制剂治疗。公司专有先导候选药物COR388是一种口服给药、可穿透脑的小分子牙龈痛抑制剂。COR388在迄今为止进行的1a期和1b期临床试验中具有良好的耐受性，没有相关的安全信号，该试验共招募了67名受试者，其中包括9名轻度至中度阿尔茨海默病患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.091321},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.017781},{"month":3,"riseRate":0.5,"avgChangeRate":0.133761},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084014},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.087389},{"month":6,"riseRate":0.714286,"avgChangeRate":0.184618},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.077216},{"month":8,"riseRate":0.428571,"avgChangeRate":0.032954},{"month":9,"riseRate":0.571429,"avgChangeRate":0.013938},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.049658},{"month":11,"riseRate":0.571429,"avgChangeRate":0.199459},{"month":12,"riseRate":0.285714,"avgChangeRate":0.079276}],"exchange":"NASDAQ","name":"Quince Therapeutics, Inc.","nameEN":"Quince Therapeutics, Inc."},"aProfile":null}}}